文献速递糖尿病

高压氧治疗糖尿病缺血性下肢溃疡:DAMO2CLES多中心随机临床试验结果

Hyperbaric Oxygen Therapy in the Treatment of Ischemic Lower- Extremity Ulcers in Patients With Diabetes: Results of the DAMO2CLES Multicenter Randomized Clinical Trial.
PubMed 文献 · Diabetes Care · 2017-10-26

该多中心随机临床试验纳入120例糖尿病合并缺血性下肢溃疡患者,随机分为标准治疗组(SC)和标准治疗加高压氧治疗组(SC+HBOT),每组60例。12个月后,两组保肢率风险差为10%(95%CI -4至23),创面愈合风险差为3%(95%CI -14至21),均无显著差异。结论认为额外高压氧治疗未显著改善创面完全愈合或保肢。

要点

  • 12个月保肢率SC组47例 vs SC+HBOT组53例,风险差10%(95%CI -4至23),无显著差异。
  • 12个月创面愈合SC组28例 vs SC+HBOT组30例,风险差3%(95%CI -14至21),无显著差异。
  • SC+HBOT组21例(35%)未能按计划完成高压氧方案,完成者大截肢更少且无截肢生存更高(风险差26%,95%CI 10-38)。

核心结论

  • 在糖尿病合并下肢缺血患者中,额外高压氧治疗未显著改善创面完全愈合或保肢。

研究设计与样本

  • 多中心随机临床试验,纳入120例糖尿病合并缺血性创面患者,随机分为标准治疗组(SC)和标准治疗加高压氧治疗组(SC+HBOT),每组60例。

主要发现

  • 12个月保肢率SC组47例 vs SC+HBOT组53例,风险差10%(95%CI -4至23)。
  • 12个月创面愈合SC组28例 vs SC+HBOT组30例,风险差3%(95%CI -14至21)。
  • 无截肢生存SC组41例 vs SC+HBOT组49例,风险差13%(95%CI -2至28)。
  • SC+HBOT组21例(35%)未能按计划完成高压氧方案;完成者大截肢显著更少且无截肢生存更高(无截肢生存风险差26%,95%CI 10-38)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Conflicting evidence exists on the effects of hyperbaric oxygen therapy (HBOT) in the treatment of chronic ischemic leg ulcers. The aim of this trial was to investigate whether additional HBOT would benefit patients with diabetes and ischemic leg ulcers. RESEARCH DESIGN AND METHODS: Patients with diabetes with an ischemic wound (n = 120) were randomized to standard care (SC) without or with HBOT (SC+HBOT). Primary outcomes were limb salvage and wound healing after 12 months, as well as time to wound healing. Other end points were amputation-free survival (AFS) and mortality. RESULTS: Both groups contained 60 patients. Limb salvage was achieved in 47 patients in the SC group vs. 53 patients in the SC+HBOT group (risk difference [RD] 10% [95% CI -4 to 23]). After 12 months, 28 index wounds were healed in the SC group vs. 30 in the SC+HBOT group (RD 3% [95% CI -14 to 21]). AFS was achieved in 41 patients in the SC group and 49 patients in the SC+HBOT group (RD 13% [95% CI -2 to 28]). In the SC+HBOT group, 21 patients (35%) were unable to complete the HBOT protocol as planned. Those who did had significantly fewer major amputations and higher AFS (RD for AFS 26% [95% CI 10-38]). CONCLUSIONS: Additional HBOT did not significantly improve complete wound healing or limb salvage in patients with diabetes and lower-limb ischemia.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Santema KTB, Stoekenbroek RM, Koelemay MJW, et al. Hyperbaric Oxygen Therapy in the Treatment of Ischemic Lower- Extremity Ulcers in Patients With Diabetes: Results of the DAMO2CLES Multicenter Randomized Clinical Trial. Diabetes Care. 2017. PMID: 29074815. doi:10.2337/dc17-0654

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。